Antifibrotic and molecular aspects of rifaximin in alcoholic liver disease: Study protocol for a randomized controlled trial

Bjørn Stæhr Madsen*, Jonel Trebicka, Maja Thiele, Mads Israelsen, Manimozhiyan Arumugan, Troels Havelund, Aleksander Krag

*Kontaktforfatter

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

259 Downloads (Pure)

Fingeraftryk

Dyk ned i forskningsemnerne om 'Antifibrotic and molecular aspects of rifaximin in alcoholic liver disease: Study protocol for a randomized controlled trial'. Sammen danner de et unikt fingeraftryk.

Medicine and Dentistry